Neville Rodie & Shaw Inc Novo Nordisk A S Transaction History

Neville Rodie & Shaw Inc

  • $1.36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 03, 2023
SELL
$102.55 - $135.33 $82,040 - $108,264
-800 Reduced 28.57%
2,000 $271,000
Q2 2022

Jul 06, 2022
SELL
$103.24 - $121.81 $851,213 - $1 Million
-8,245 Reduced 74.65%
2,800 $312,000
Q4 2021

Jan 05, 2022
BUY
$95.88 - $117.08 $1.06 Million - $1.29 Million
11,045 New
11,045 $1.24 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email